Company News

Company News
April 29, 2021
Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech
Vancouver, British Columbia, Canada – April 29, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”), a biotechnology research...
Read more
Company News
April 28, 2021
CORE ONE LABS ANNOUNCES DELAY OF FILINGS
Vancouver, British Columbia, Canada – April 28, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”)...
Read more
Company News
April 28, 2021
Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin
Vancouver, British Columbia, Canada – April 28, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
April 24, 2021
Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
Vancouver, British Columbia, Canada – April 24, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
April 21, 2021
Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
Vancouver, British Columbia, Canada – April 21, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”)...
Read more
Company News
April 17, 2021
Core One Labs Negotiates Milestone Acquisition With Akome Biotech Ltd.
Vancouver, British Columbia, Canada – April 17, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) a biotechnology research and development...
Read more